NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球轉染市場-至2028年的產業趨勢與預測

Global Transfection Market - Industry Trends and Forecast to 2028

出版商 Data Bridge Market Research Private Limited 商品編碼 977681
出版日期 內容資訊 英文 830 Pages
商品交期: 3-5個工作天內
價格
全球轉染市場-至2028年的產業趨勢與預測 Global Transfection Market - Industry Trends and Forecast to 2028
出版日期: 2020年11月01日內容資訊: 英文 830 Pages
簡介

全球轉染的市場規模,預計從2020年到2028年的預測期間以9.6%健全的年複合成長率擴大。這個新的市場報告,包含2018年的成果,與從作為基準年的2019年,2020年至2027年的預測資料。

本報告提供全球轉染市場相關調查,市場概要,以及各類型,各方法,各產品,各分子類型,各用途,各階段,各終端用戶,各國的趨勢,及加入此市場的主要企業簡介等資訊

目錄

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 重要考察

  • 市場整體趨勢
    • 各方法/模式
    • 各終端用戶
    • 各用途
    • 各階段
  • 生物醫藥品的初期及後期階段的細胞株開發及基因治療的病毒載體生產
    • 用中國倉鼠卵巢(CHO)細胞產生的已通過核准抗體清單及哺乳類的表現媒介使用的可選擇的標記清單

第5章 法律規範

  • 歐洲聯盟的法規方案
  • 美國的法規方案
  • 日本的法規方案
  • 中國的法規方案

第6章 市場概要

  • 促進因素
    • 慢性疾病的盛行率的上升
    • 合成生物學產品的開發
    • 嵌合遺傳基因的需求高漲
    • 臨床研究所使用的大規模轉染
    • 蛋白質的產生中生物醫藥品的使用
  • 阻礙因素
    • 轉染產品的成本高
    • 轉染試劑的選擇性有效性
    • 根據轉染次序引起的細胞損傷
  • 市場機會
    • 新興市場開拓
    • 市場參與者的策略性舉措
    • 政府的輔助增加
    • 劇增的投資等級
  • 課題
    • 長期批審
    • 病毒相關轉染的安全等級的實驗室的缺乏
    • 受到了訓練的專家的不足

第7章 COVID-19醫療保健產業中COVID-19對全球轉染市場的影響

  • 概要
  • 對價格的影響
  • 對需求的影響
  • 對供應鏈的影響
  • 製造商的策略性舉措
  • 結論

第8章 全球轉染市場,各類型

  • 概要
  • 一時性轉染
    • 各階段
    • 各產品
  • 穩定性轉染
    • 各階段
    • 各產品

第9章 全球轉染市場,各方法

  • 概要
  • 非病毒性方法
    • 化學
    • 物理
  • 病毒法
    • 反轉錄病毒轉染
    • 腺病毒轉染
    • 慢病毒轉染
    • 其他

第10章 全球轉染市場,各方法

  • 概要
  • 非病毒性的方法
    • 化學
    • 物理
  • 病毒法
    • 反轉錄病毒轉染
    • 腺病毒轉染
    • 慢病毒轉染
    • 其他

第11章 全球轉染市場,各產品

  • 概要
  • 試劑和套件
    • 陽離子性脂質
    • 陽離子聚合物
    • 奈米粒子
    • 套件
    • CUVETTE CHAMBER
    • 其他
  • 計量儀器
    • 電穿孔系統
    • 電力細胞融合發電機
    • 動電學性轉染系統
    • HEPTA系統
    • 管道準備站
    • RT-PCR
    • 槍系統
    • 微量盤式分析儀
    • SONOPORATION系統
    • 顯微鏡
    • 其他

第12章 全球轉染市場,各生物

  • 概要
  • 哺乳類細胞
  • 植物
  • 真菌
  • 病毒
  • 細菌

第13章 全球轉染市場,各分子類型

  • 概要
  • 質體DNA
  • 低分子干涉RNA(SIRNA)
  • 蛋白質
  • DNA寡核苷酸
  • 核糖核蛋白複合物(RNPS)
  • 其他

第14章 全球轉染市場,各用途

  • 概要
  • 各類型
    • in vitro
    • in vivo
    • 生物生產
    • 其他
  • 各業界
    • 合成生物學
    • 農業
    • 其他

第15章 全球轉染市場,各階段

  • 概要
  • 研究
  • 前臨床
  • 臨床階段
  • 商用

第16章 全球轉染市場,各終端用戶

  • 概要
  • 生物醫藥品
  • 醫藥品研究開發受託機關(CROS)
  • 醫藥品研究開發、受託製造廠商(CMOS/CDMOS)
  • 學術機構
  • 醫院
  • 臨床實驗室
  • 其他

第17章 全球轉染市場,各流通管道

  • 概要
  • 直接競標
  • 零售
  • 其他

第18章 全球轉染市場,各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 西班牙
    • 瑞士
    • 俄羅斯
    • 荷蘭
    • 比利時
    • 土耳其
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印尼
    • 菲律賓
    • 其他
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 中東、非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 埃及
    • 其他

第19章 全球 MARKET轉染:企業形勢

  • 企業佔有率分析:世界
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第20章 SWOT分析

第21章 企業簡介

  • THERMOFISHER SCIENTIFIC INC.
  • ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
  • QIAGEN
  • PROMEGA CORPORATION
  • TAKARA BIO INC.
  • BIO-RAD LABORATORIES, INC.
  • LONZA
  • CYTIVA
  • ALTOGEN BIOSYSTEMS
  • AMYRIS
  • APPLIED BIOLOGICAL MATERIALS INC. (ABM)
  • AUTOLUS
  • AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
  • BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
  • CODEXIS
  • CONAGEN, INC.
  • FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
  • GENLANTIS INC.
  • GENO TECHNOLOGY INC., USA
  • GINKGO BIOWORKS
  • IMPOSSIBLE FOODS INC
  • MAXCYTE, INC.
  • MERCK KGAA
  • MIRUS BIO LLC.
  • ORIGENE TECHNOLOGIES, INC.
  • PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
  • POLYPLUS TRANSFECTION
  • POSEIDA THERAPEUTICS, INC.
  • R&D SYSTEMS, INC.
  • SBS GENETECH
  • SIGNAGEN LABORATORIES
  • TWIST BIOSCIENCE
  • VERVE THERAPEUTICS, INC.
  • ZYMERGEN INC.

第22章 問卷調查

第23章 相關報告

目錄

Global transfection market is projected to register a healthy CAGR of 9.6% in the forecast period of 2020 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.

Market Segmentation:

Global Transfection Market, By Type (Transient Transfection, Stable Transfection), Methods (Non-Viral Methods, Viral Methods), CRISPR Transfection Methods (Non-Viral Methods, Viral Methods), Products (Reagent & Kits, Instrument, Software), Organism (Mammalian Cells, Plants, Fungi, Virus, Bacteria), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), Others), Application (In Vitro Application, In Vivo Application, Bioproduction, Others), Stage (Research, Preclinical, Clinical Phases, Commercial), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Belgium, Ireland, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific , Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Egypt, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

Some of the major factors contributing to the growth of global transfection market are:

  • Development of synthetic biology products
  • Increasing government support

Market Players:

The key market players for global transfection market are listed below:

  • Mirus Bio LLC.
  • Promega Corporation
  • Polyplus Transfection
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Lonza
  • MaxCyte, Inc.
  • Altogen Biosystems
  • SBS Genetech
  • FUJIFILM Irvine Scientific (A Subsidiary of FUJIFILM Holdings Corporation)
  • Avanti Polar Lipids (A Subsidiary of Croda International Plc)
  • PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.)
  • Cytiva
  • Geno Technology Inc., USA
  • R&D Systems, Inc.
  • Takara Bio Inc.
  • Thermofisher Scientific Inc.
  • Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd)
  • QIAGEN
  • OriGene Technologies, Inc.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL TRANSFECTION MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

  • 4.1 TOTAL ADDRESSABLE MARKET
    • 4.1.1 BY METHOD/MODALITY
    • 4.1.2 BY END USER
    • 4.1.3 BY APPLICATION
    • 4.1.4 BY STAGE
  • 4.2 EARLY AND LATE STAGE CELL LINE DEVELOPMENT FOR BIOPHARMA AND VIRAL VECTOR PRODUCTION FOR GENE THERAPY
    • 4.2.1 THE LIST OF APPROVED ANTIBODIES PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS AND LIST OF SELECTABLE MARKERS USED IN MAMMALIAN EXPRESSION VECTORS

5 REGULATORY FRAMEWORK

  • 5.1 EUROPEAN UNION REGULATORY SCENARIO
  • 5.2 U.S. REGULATORY SCENARIO
  • 5.3 JAPAN REGULATORY SCENARIO
  • 5.4 CHINA REGULATORY SCENARIO

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES
    • 6.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS
    • 6.1.3 GROWING DEMAND OF CHIMERIC GENES
    • 6.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH
    • 6.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS
  • 6.2 RESTRAINTS
    • 6.2.1 HIGH COST OF TRANSFECTION PRODUCTS
    • 6.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS
    • 6.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE
  • 6.3 OPPORTUNITIES
    • 6.3.1 EXPLORATION OF EMERGING MARKET
    • 6.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
    • 6.3.3 INCREASING GOVERNMENT SUPPORT
    • 6.3.4 SURGING LEVEL OF INVESTMENT
  • 6.4 CHALLENGES
    • 6.4.1 LONG APPROVAL PROCEDURE
    • 6.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS ASSOCIATED TRANSFECTION
    • 6.4.3 LACK OF TRAINED PROFESSIONALS

7 COVID-19 IMPACT OF GLOBAL TRANSFECTION MARKET IN HEALTHCARE INDUSTRY

  • 7.1 OVERVIEW
  • 7.2 IMPACT ON THE PRICE
  • 7.3 IMPACT ON DEMAND
  • 7.4 IMPACT ON SUPPLY CHAIN
  • 7.5 STRATEGIC INITIATIVE BY MANUFACTURERS
  • 7.6 CONCLUSION

8 GLOBAL TRANSFECTION MARKET, BY TYPE

  • 8.1 OVERVIEW
  • 8.2 TRANSIENT TRANSFECTION
    • 8.2.1 BY STAGE
      • 8.2.1.1 RESEARCH
      • 8.2.1.2 PRECLINICAL
      • 8.2.1.3 CLINICAL PHASES
      • 8.2.1.4 COMMERCIAL
    • 8.2.2 BY PRODUCT
      • 8.2.2.1 REAGENT & KITS
      • 8.2.2.2 INSTRUMENTS
      • 8.2.2.3 SOFTWARE
  • 8.3 STABLE TRANSECTION
    • 8.3.1 BY STAGE
      • 8.3.1.1 RESEARCH
      • 8.3.1.2 PRECLINICAL
      • 8.3.1.3 CLINICAL PHASES
      • 8.3.1.4 COMMERCIAL
    • 8.3.2 BY PRODUCT
      • 8.3.2.1 REAGENT & KITS
      • 8.3.2.2 INSTRUMENTS
      • 8.3.2.3 SOFTWARE

9 GLOBAL TRANSFECTION MARKET, BY METHODS

  • 9.1 2.1 OVERVIEW
  • 9.2 NON- VIRAL METHODS
    • 9.2.1 CHEMICAL
      • 9.2.1.1 Lipofection Method
      • 9.2.1.2 Calcium Phosphate Precipitation Method
      • 9.2.1.3 Polyethylenimine (PEI)-DNA Condensation Method
      • 9.2.1.4 Others
    • 9.2.2 PHYSICAL
      • 9.2.2.1 Electroporation
      • 9.2.2.2 Direct Microinjection
      • 9.2.2.3 Biolistic Particle Delivery/ Particle Bombardment
      • 9.2.2.4 Magnetofection
      • 9.2.2.5 Sonoporation
      • 9.2.2.6 Others
  • 9.3 VIRAL METHODS
    • 9.3.1 RETROVIRUS TRANSFECTION
    • 9.3.2 ADENOVIRUS TRANSFECTION
    • 9.3.3 LENTIVIRUS TRANSFECTION
    • 9.3.4 OTHERS

10 GLOBAL TRANSFECTION MARKET, BY METHODS

  • 10.1 OVERVIEW
  • 10.2 NON- VIRAL METHODS
    • 10.2.1 CHEMICAL
      • 10.2.1.1 Lipofection Method
      • 10.2.1.2 Calcium Phosphate Precipitation Method
      • 10.2.1.3 Polyethylenimine (PEI)-DNA Condensation Method
      • 10.2.1.4 Others
    • 10.2.2 PHYSICAL
      • 10.2.2.1 Electroporation
      • 10.2.2.2 Direct Microinjection
      • 10.2.2.3 Biolistic Particle Delivery/ Particle Bombardment
      • 10.2.2.4 Magnetofection
      • 10.2.2.5 Sonoporation
      • 10.2.2.6 Others
  • 10.3 VIRAL METHODS
    • 10.3.1 RETROVIRUS TRANSFECTION
    • 10.3.2 ADENOVIRUS TRANSFECTION
    • 10.3.3 LENTIVIRUS TRANSFECTION
    • 10.3.4 OTHERS

11 GLOBAL TRANSFECTION MARKET, BY PRODUCTS

  • 11.1 OVERVIEW
  • 11.2 REAGENTS & KITS
    • 11.2.1 CATIONIC LIPIDS
      • 11.2.1.1 Liposomal Reagents
        • 11.2.1.1.1 L-Dioleoyl Phosphatidylethanolamine (DOPE)
        • 11.2.1.1.2 DOTAP [1,2-Dioleoyloxy-3-Trimethylammonium Propane]
        • 11.2.1.1.3 DOTMA [N-[1(2,3-Dioleoyloxy)Propyl]-N,N,N-Trimethylammonium Chloride]
        • 11.2.1.1.4 Others
      • 11.2.1.2 Non-Liposomal Reagents
        • 11.2.1.2.1 DNA Transfection Reagent
        • 11.2.1.2.2 siRNA Transfection Reagent
        • 11.2.1.2.3 Others
    • 11.2.2 CATIONIC POLYMER
      • 11.2.2.1 DEAE-Dextran
      • 11.2.2.2 Polybrene
      • 11.2.2.3 Polyethyleneimine
      • 11.2.2.4 Dendrimers
      • 11.2.2.5 Others
    • 11.2.3 NANOPARTICLES
      • 11.2.3.1 Systemic Intravenous Injection
      • 11.2.3.2 Direct Intratumoral Injection
    • 11.2.4 KITS
      • 11.2.4.1 Transporter Transfection Reagent
      • 11.2.4.2 GMP Transfection Reagent
      • 11.2.4.3 Neon Electroporation
      • 11.2.4.4 Cellfectin Ii Transfection Reagent
      • 11.2.4.5 DMRIE-C Transfection Reagent
      • 11.2.4.6 Lipofectamine Transfection Reagent
      • 11.2.4.7 Lipofectin Transfection Reagent
      • 11.2.4.8 Oligofectamine Transfection Reagent
      • 11.2.4.9 Optifect Transfection Reagent
      • 11.2.4.10 Cell Specific Transfection Reagent
      • 11.2.4.11 Gene Gun Kit
      • 11.2.4.12 Plasmid Transfection Reagent
      • 11.2.4.13 Others
    • 11.2.5 CUVETTE CHAMBER
    • 11.2.6 OTHERS
  • 11.3 INSTRUMENT
    • 11.3.1 ELECTROPORATION SYSTEM
      • 11.3.1.1 Neon Transfection System
      • 11.3.1.2 Others
    • 11.3.2 ELECTRO-CELL FUSION GENERATOR
    • 11.3.3 ELECTRO-KINETIC TRANSFECTION SYSTEM
    • 11.3.4 HEPTA SYSTEM
    • 11.3.5 TUBING PREP STATION
    • 11.3.6 RT-PCR
    • 11.3.7 GUN SYSTEM
    • 11.3.8 MICROPLATE READER
    • 11.3.9 SONOPORATION SYSTEM
    • 11.3.10 MICROSCOPES
    • 11.3.11 OTHERS

12 GLOBAL TRANSFECTION MARKET, BY ORGANISM

  • 12.1 OVERVIEW
  • 12.2 MAMMALIAN CELLS
  • 12.3 PLANTS
  • 12.4 FUNGI
  • 12.5 VIRUS
  • 12.6 BACTERIA

13 GLOBAL TRANSFECTION MARKET, BY TYPES OF MOLECULE

  • 13.1 OVERVIEW
  • 13.2 PLASMID DNA
  • 13.3 SMALL INTERFERING RNA (SIRNA)
  • 13.4 PROTEINS
  • 13.5 DNA OLIGONUCLEOTIDES
  • 13.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS)
  • 13.7 OTHERS

14 GLOBAL TRANSFECTION MARKET, BY APPLICATION

  • 14.1 OVERVIEW
  • 14.2 BY TYPE
    • 14.2.1 IN VITRO APPLICATION
      • 14.2.1.1 Gene Expression
      • 14.2.1.2 RNA Interference
    • 14.2.2 IN VIVO APPLICATION
      • 14.2.2.1 Gene Therapy
      • 14.2.2.2 Cellular-Based Therapy
    • 14.2.3 BIOPRODUCTION
      • 14.2.3.1 Antibody/Protein Production
      • 14.2.3.2 Virus Production
    • 14.2.4 OTHERS
  • 14.3 BY INDUSTRY
    • 14.3.1 SYNTHETIC BIOLOGY
      • 14.3.1.1 Biopharma
      • 14.3.1.2 Monoclonal Antibodies (mAbs)
      • 14.3.1.3 Recombinant Proteins
      • 14.3.1.4 Biofuels
      • 14.3.1.5 Cell Line Development
      • 14.3.1.6 Flavors & Fragrances
      • 14.3.1.7 Enzyme Engineering & Production
      • 14.3.1.8 Specialty Chemicals
    • 14.3.2 AGRICULTURE
    • 14.3.3 OTHERS

15 GLOBAL TRANSFECTION MARKET, BY STAGES

  • 15.1 OVERVIEW
  • 15.2 RESEARCH
  • 15.3 PRECLINICAL
  • 15.4 CLINICAL PHASES
  • 15.5 COMMERCIAL

16 GLOBAL TRANSFECTION MARKET, BY END USER

  • 16.1 OVERVIEW
  • 16.2 BIOPHARMA
  • 16.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
  • 16.4 CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS)
  • 16.5 ACADEMIA
  • 16.6 HOSPITALS
  • 16.7 CLINICAL LABS
  • 16.8 OTHERS

17 GLOBAL TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL

  • 17.1 OVERVIEW
  • 17.2 DIRECT TENDERS
  • 17.3 RETAIL SALES
  • 17.4 OTHERS

18 GLOBAL TRASNFECTION MARKET, BY GEOGRAPHY

  • 18.1 OVERVIEW
  • 18.2 NORTH AMERICA
    • 18.2.1 U.S.
    • 18.2.2 CANADA
    • 18.2.3 MEXICO
  • 18.3 EUROPE
    • 18.3.1 GERMANY
    • 18.3.2 FRANCE
    • 18.3.3 ITALY
    • 18.3.4 U.K.
    • 18.3.5 SPAIN
    • 18.3.6 SWITZERLAND
    • 18.3.7 RUSSIA
    • 18.3.8 NETHERLANDS
    • 18.3.9 BELGIUM
    • 18.3.10 TURKEY
    • 18.3.11 REST OF EUROPE
  • 18.4 ASIA PACIFIC
    • 18.4.1 CHINA
    • 18.4.2 JAPAN
    • 18.4.3 INDIA
    • 18.4.4 AUSTRALIA
    • 18.4.5 SOUTH KOREA
    • 18.4.6 SINGAPORE
    • 18.4.7 THAILAND
    • 18.4.8 MALAYSIA
    • 18.4.9 INDONESIA
    • 18.4.10 PHILIPPINES
    • 18.4.11 REST OF ASIA- PACIFIC
  • 18.5 SOUTH AMERICA
    • 18.5.1 BRAZIL
    • 18.5.2 ARGENTINA
    • 18.5.3 REST OF SOUTH AMERICA
  • 18.6 MIDDLE EAST & AFRICA
    • 18.6.1 SOUTH AFRICA
    • 18.6.2 SAUDI ARABIA
    • 18.6.3 UAE
    • 18.6.4 ISRAEL
    • 18.6.5 EGYPT
    • 18.6.6 REST OF MIDDLE EAST & AFRICA

19 GLOBAL TRANSFECTION MARKET: COMPANY LANDSCAPE

  • 19.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 19.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 19.3 COMPANY SHARE ANALYSIS: EUROPE
  • 19.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

20 SWOT ANALYSIS

21 COMPANY PROFILE

  • 21.1 THERMOFISHER SCIENTIFIC INC.
    • 21.1.1 COMPANY SNAPSHOT
    • 21.1.2 REVENUE ANALYSIS
    • 21.1.3 COMPANY SHARE ANALYSIS
    • 21.1.4 PRODUCT PORTFOLIO
    • 21.1.5 RECENT DEVELOPMENTS
  • 21.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
    • 21.2.1 COMPANY SNAPSHOT
    • 21.2.2 REVENUE ANALYSIS
    • 21.2.3 COMAPYN SHARE ANALYSIS
    • 21.2.4 PRODUCT PORTFOLIO
    • 21.2.5 RECENT DEVELOPMENTS
  • 21.3 QIAGEN
    • 21.3.1 COMPANY SNAPSHOT
    • 21.3.2 REVENUE ANALYSIS
    • 21.3.3 COMPANY SHARE ANALYSIS
    • 21.3.4 PRODUCT PORTFOLIO
    • 21.3.5 RECENT DEVELOPMENTS
  • 21.4 PROMEGA CORPORATION
    • 21.4.1 COMPANY SNAPSHOT
    • 21.4.2 COMPANY SHARE ANALYSIS
    • 21.4.3 PRODUCT PORTFOLIO
    • 21.4.4 RECENT DEVELOPMENTS
  • 21.5 TAKARA BIO INC.
    • 21.5.1 COMPANY SNAPSHOT
    • 21.5.2 REVENUE ANALYSIS
    • 21.5.3 COMPANY SHARE ANALYSIS
    • 21.5.4 PRODUCT PORTFOLIO
    • 21.5.5 RECENT DEVELOPMENTS
  • 21.6 BIO-RAD LABORATORIES, INC.
    • 21.6.1 COMPANY SNAPSHOT
    • 21.6.2 REVENUE ANANLYSIS
    • 21.6.3 PRODUCT PORTFOLIO
    • 21.6.4 RECENT DEVELOPMENT
  • 21.7 LONZA
    • 21.7.1 COMPANY SNAPSHOT
    • 21.7.2 REVENUE ANANLYSIS
    • 21.7.3 PRODUCT PORTFOLIO
    • 21.7.4 RECENT DEVELOPMENTS
  • 21.8 CYTIVA
    • 21.8.1 COMPANY SNAPSHOT
    • 21.8.2 PRODUCT PORTFOLIO
    • 21.8.3 RECENT DEVELOPMENTS
  • 21.9 ALTOGEN BIOSYSTEMS
    • 21.9.1 COMPANY SNAPSHOT
    • 21.9.2 PRODUCT PORTFOLIO
    • 21.9.3 RECENT DEVELOPMENTS
  • 21.10 AMYRIS
    • 21.10.1 COMPANY SNAPSHOT
    • 21.10.2 REVENUE ANALYSIS
    • 21.10.3 PRODUCT PORTFOLIO
    • 21.10.4 RECENT DEVELOPMENTS
  • 21.11 APPLIED BIOLOGICAL MATERIALS INC. (ABM)
    • 21.11.1 COMPANY SNAPSHOT
    • 21.11.2 PRODUCT PORTFOLIO
    • 21.11.3 RECENT DEVELOPMENT
  • 21.12 AUTOLUS
    • 21.12.1 COMPANY SNAPSHOT
    • 21.12.2 PRODUCT PORTFOLIO
    • 21.12.3 RECENT DEVELOPMENTS
  • 21.13 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
    • 21.13.1 COMPANY SNAPSHOT
    • 21.13.2 REVENUE ANALYSIS
    • 21.13.3 PRODUCT PORTFOLIO
    • 21.13.4 RECENT DEVELOPMENT
  • 21.14 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
    • 21.14.1 COMPANY SNAPSHOT
    • 21.14.2 REVENUE ANALYSIS
    • 21.14.3 PRODUCT PORTFOLIO
    • 21.14.4 RECENT DEVELOPMENTS
  • 21.15 CODEXIS
    • 21.15.1 COMPANY SNAPSHOT
    • 21.15.2 REVENUE ANALYSIS
    • 21.15.3 PRODUCT PORTFOLIO
    • 21.15.4 RECENT DEVELOPMENTS
  • 21.16 CONAGEN, INC.
    • 21.16.1 COMPANY SNAPSHOT
    • 21.16.2 PRODUCT PORTFOLIO
    • 21.16.3 RECENT DEVELOPMENTS
  • 21.17 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
    • 21.17.1 COMPANY SNAPSHOT
    • 21.17.2 REVENUE ANANLYSIS
    • 21.17.3 PRODUCT PORTFOLIO
    • 21.17.4 RECENT DEVELOPMENT
  • 21.18 GENLANTIS INC.
    • 21.18.1 COMPANY SNAPSHOT
    • 21.18.2 PRODUCT PORTFOLIO
    • 21.18.3 RECENT DEVELOPMENTS
  • 21.19 GENO TECHNOLOGY INC., USA
    • 21.19.1 COMPANY SNAPSHOT
    • 21.19.2 PRODUCT PORTFOLIO
    • 21.19.3 RECENT DEVELOPMENTS
  • 21.20 GINKGO BIOWORKS
    • 21.20.1 COMPANY SNAPSHOT
    • 21.20.2 PRODUCT PORTFOLIO
    • 21.20.3 RECENT DEVELOPMENTS
  • 21.21 IMPOSSIBLE FOODS INC
    • 21.21.1 COMPANY SNAPSHOT
    • 21.21.2 PRODUCT PORTFOLIO
    • 21.21.3 RECENT DEVELOPMENTS
  • 21.22 MAXCYTE, INC.
    • 21.22.1 COMPANY SNAPSHOT
    • 21.22.2 REVENUE ANALYSIS
    • 21.22.3 PRODUCT PORTFOLIO
    • 21.22.4 RECENT DEVELOPMENTS
  • 21.23 MERCK KGAA
    • 21.23.1 COMPANY SNAPSHOT
    • 21.23.2 REVENUE ANALYSIS
    • 21.23.3 PRODUCT PORTFOLIO
    • 21.23.4 RECENT DEVELOPMENTS
  • 21.24 MIRUS BIO LLC.
    • 21.24.1 COMPANY SNAPSHOT
    • 21.24.2 PRODUCT PORTFOLIO
    • 21.24.3 RECENT DEVELOPMENTS
  • 21.25 ORIGENE TECHNOLOGIES, INC.
    • 21.25.1 COMPANY SNAPSHOT
    • 21.25.2 PRODUCT PORTFOLIO
    • 21.25.3 RECENT DEVELOPMENTS
  • 21.26 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
    • 21.26.1 COMPANY SNAPSHOT
    • 21.26.2 REVENUE ANANLYSIS
    • 21.26.3 PRODUCT PORTFOLIO
    • 21.26.4 RECENT DEVELOPMENTS
  • 21.27 POLYPLUS TRANSFECTION
    • 21.27.1 COMPANY SNAPSHOT
    • 21.27.2 PRODUCT PORTFOLIO
    • 21.27.3 RECENT DEVELOPMENTS
  • 21.28 POSEIDA THERAPEUTICS, INC.
    • 21.28.1 COMPANY SNAPSHOT
    • 21.28.2 PRODUCT PORTFOLIO
    • 21.28.3 RECENT DEVELOPMENTS
  • 21.29 R&D SYSTEMS, INC.
    • 21.29.1 COMPANY SNAPSHOT
    • 21.29.2 PRODUCT PORTFOLIO
    • 21.29.3 RECENT DEVELOPMENT
  • 21.30 SBS GENETECH
    • 21.30.1 COMPANY SNAPSHOT
    • 21.30.2 PRODUCT PORTFOLIO
    • 21.30.3 RECENT DEVELOPMENTS
  • 21.31 SIGNAGEN LABORATORIES
    • 21.31.1 COMPANY SNAPSHOT
    • 21.31.2 PRODUCT PORTFOLIO
    • 21.31.3 RECENT DEVELOPMENTS
  • 21.32 TWIST BIOSCIENCE
    • 21.32.1 COMPANY SNAPSHOT
    • 21.32.2 REVENUE ANALYSIS
    • 21.32.3 PRODUCT PORTFOLIO
    • 21.32.4 RECENT DEVELOPMENTS
  • 21.33 VERVE THERAPEUTICS, INC.
    • 21.33.1 COMPANY SNAPSHOT
    • 21.33.2 PRODUCT PORTFOLIO
    • 21.33.3 RECENT DEVELOPMENTS
  • 21.34 ZYMERGEN INC.
    • 21.34.1 COMPANY SNAPSHOT
    • 21.34.2 PRODUCT PORTFOLIO
    • 21.34.3 RECENT DEVELOPMENTS

22 QUESTIONNAIRE

23 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF APPROVED ANTIBODIES PRODUCED IN CHO CELLS
  • TABLE 2 EU DIRECTIVES AND REGULATIONS RELATED TO CLINICAL TRIALS INVOLVING GTMPS
  • TABLE 3 GOVERNMENT ENTITIES THAT ARE IN CHARGE OF TYPE 2 USES
  • TABLE 4 GLOBAL TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 5 GLOBAL TRANSIENT TRANSFECTION IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 6 GLOBAL TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 7 GLOBAL TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 8 GLOBAL STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 9 GLOBAL STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 10 GLOBAL TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 11 GLOBAL NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 12 GLOBAL NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 13 GLOBAL CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 14 GLOBAL PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 15 GLOBAL VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 16 GLOBAL VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 17 GLOBAL CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 18 GLOBAL NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 19 GLOBAL NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 20 GLOBAL CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 21 GLOBAL PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 22 GLOBAL VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 23 GLOBAL VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 24 GLOBAL REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 25 GLOBAL REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 26 GLOBAL CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 27 GLOBAL LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 28 GLOBAL NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 29 GLOBAL CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 30 GLOBAL NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 31 GLOBAL KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 32 GLOBAL INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 33 GLOBAL INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 34 GLOBAL ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 35 GLOBAL SOFTWARE BY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 36 NORTH AMERICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 37 GLOBAL MAMMALIAN CELLS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 38 GLOBAL PLANTS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 39 GLOBAL FUNGI IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 40 GLOBAL VIRUS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 41 GLOBAL BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 42 GLOBAL TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 43 GLOBAL PLASMID DNA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 44 GLOBAL BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 45 GLOBAL PROTEINS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 46 GLOBAL DNA OLIGONUCLEOTIDES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 47 GLOBAL RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 48 GLOBAL BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 49 GLOBALTRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 50 GLOBAL IN VITRO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 51 NORTH AMERICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 52 GLOBAL IN VIVO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 54 GLOBAL BIOPRODUCTION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 55 NORTH AMERICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 56 GLOBAL OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 57 GLOBAL TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 58 GLOBAL SYNTHETIC BIOLOGY IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 59 NORTH AMERICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 60 GLOBAL AGRICULTURE IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 61 GLOBAL OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 62 NORTH AMERICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 63 GLOBAL RESEARCH IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 64 GLOBAL PRE-CLINICAL IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 65 GLOBAL CLINICAL PHASES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 66 GLOBAL COMMERCIAL IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 67 NORTH AMERICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 68 GLOBAL BIOPHARMA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 69 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 70 GLOBAL CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 71 GLOBAL ACADEMIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 72 GLOBAL HOSPITALS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 73 GLOBAL CLINICAL LABS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 74 GLOBAL OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 75 NORTH AMERICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 76 GLOBAL DIRECT TENDER IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 77 GLOBAL RETAIL SALES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 78 GLOBAL OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 1 GLOBAL TRANSFECTION MARKET, BY REGION, 2018-2028 (USD MILLION)
  • TABLE 2 NORTH AMERICA TRANSFECTION MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
  • TABLE 3 NORTH AMERICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 4 NORTH AMERICA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 5 NORTH AMERICA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 6 NORTH AMERICA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 7 NORTH AMERICA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 8 NORTH AMERICA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 9 NORTH AMERICA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 10 NORTH AMERICA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 11 NORTH AMERICA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 12 NORTH AMERICA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 13 NORTH AMERICA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 14 NORTH AMERICA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 15 NORTH AMERICA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 16 NORTH AMERICA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 17 NORTH AMERICA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 18 NORTH AMERICA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 19 NORTH AMERICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 20 NORTH AMERICA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 21 NORTH AMERICA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 22 NORTH AMERICA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 23 NORTH AMERICA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 24 NORTH AMERICA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 25 NORTH AMERICA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 26 NORTH AMERICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 27 NORTH AMERICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 28 NORTH AMERICA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 29 NORTH AMERICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 30 NORTH AMERICA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 31 NORTH AMERICATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 32 NORTH AMERICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 33 NORTH AMERICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 34 NORTH AMERICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 35 NORTH AMERICA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 36 NORTH AMERICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 37 NORTH AMERICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 38 NORTH AMERICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 39 NORTH AMERICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 40 U.S. TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 41 U.S. TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 42 U.S. TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 43 U.S. STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 44 U.S. STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 45 U.S. TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 46 U.S. NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 47 U.S. CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 48 U.S. PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 49 U.S. VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 50 U.S. CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 51 U.S. NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 52 U.S. CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 53 U.S. PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 54 U.S. VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 55 U.S. TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 56 U.S. REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 57 U.S. CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 58 U.S. LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 59 U.S. NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 60 U.S. CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 61 U.S. KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 62 U.S. NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 63 U.S. INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 64 U.S. INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 65 U.S. ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 66 U.S. TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 67 U.S. TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 68 U.S. TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 69 U.S. IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 70 U.S. IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 71 U.S. BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 72 U.S. TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 73 U.S. SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 74 U.S. TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 75 U.S. TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 76 U.S. TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 77 CANADA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 78 CANADA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 79 CANADA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 80 CANADA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 81 CANADA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 82 CANADA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 83 CANADA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 84 CANADA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 85 CANADA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 86 CANADA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 87 CANADA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 88 CANADA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 89 CANADA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 90 CANADA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 91 CANADA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 92 CANADA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 93 CANADA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 94 CANADA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 95 CANADA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 96 CANADA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 97 CANADA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 98 CANADA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 99 CANADA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 100 CANADA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 101 CANADA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 102 CANADA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 103 CANADA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 104 CANADA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 105 CANADA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 106 CANADA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 107 CANADA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 108 CANADA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 109 CANADA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 110 CANADA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 111 CANADA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 112 CANADA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 113 CANADA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 114 MEXICO TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 115 MEXICO TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 116 MEXICO TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 117 MEXICO STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 118 MEXICO STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 119 MEXICO TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 120 MEXICO NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 121 MEXICO CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 122 MEXICO PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 123 MEXICO VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 124 MEXICO CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 125 MEXICO NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 126 MEXICO CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 127 MEXICO PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 128 MEXICO VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 129 MEXICO TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 130 MEXICO REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 131 MEXICO CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 132 MEXICO LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 133 MEXICO NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 134 MEXICO CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 135 MEXICO KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 136 MEXICO NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 137 MEXICO INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 138 MEXICO INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 139 MEXICO ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 140 MEXICO TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 141 MEXICO TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 142 MEXICO TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 143 MEXICO IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 144 MEXICO IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 145 MEXICO BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 146 MEXICO TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 147 MEXICO SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 148 MEXICO TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 149 MEXICO TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 150 MEXICO TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 151 EUROPE TRANSFECTION MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
  • TABLE 152 EUROPE TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 153 EUROPE TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 154 EUROPE TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 155 EUROPE STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 156 EUROPE STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 157 EUROPE TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 158 EUROPE NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 159 EUROPE CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 160 EUROPE PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 161 EUROPE VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 162 EUROPE CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 163 EUROPE NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 164 EUROPE CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 165 EUROPE PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 166 EUROPE VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 167 EUROPE TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 168 EUROPE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 169 EUROPE CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 170 EUROPE LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 171 EUROPE NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 172 EUROPE CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 173 EUROPE KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 174 EUROPE NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 175 EUROPE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 176 EUROPE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 177 EUROPE ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 178 EUROPE TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 179 EUROPE TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 180 EUROPE AMERICATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 181 EUROPE IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 182 EUROPE IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 183 EUROPE BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 184 EUROPE TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 185 EUROPE SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 186 EUROPE TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 187 EUROPE TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 188 EUROPE TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 189 GERMANY TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 190 GERMANY TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 191 GERMANY TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 192 GERMANY STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 193 GERMANY STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 194 GERMANY TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 195 GERMANY NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 196 GERMANY CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 197 GERMANY PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 198 GERMANY VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 199 GERMANY CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 200 GERMANY NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 201 GERMANY CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 202 GERMANY PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 203 GERMANY VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 204 GERMANY TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 205 GERMANY REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 206 GERMANY CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 207 GERMANY LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 208 GERMANY NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 209 GERMANY CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 210 GERMANY KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 211 GERMANY NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 212 GERMANY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 213 GERMANY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 214 GERMANY ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 215 GERMANY TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 216 GERMANY TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 217 GERMANY TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 218 GERMANY IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 219 GERMANY IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 220 GERMANY BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 221 GERMANY TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 222 GERMANY SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 223 GERMANY TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 224 GERMANY TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 225 GERMANY TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 226 FRANCE TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 227 FRANCE TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 228 FRANCE TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 229 FRANCE STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 230 FRANCE STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 231 FRANCE TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 232 FRANCE NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 233 FRANCE CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 234 FRANCE PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 235 FRANCE VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 236 FRANCE CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 237 FRANCE NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 238 FRANCE CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 239 FRANCE PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 240 FRANCE VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 241 FRANCE TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 242 FRANCE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 243 FRANCE CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 244 FRANCE LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 245 FRANCE NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 246 FRANCE CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 247 FRANCE KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 248 FRANCE NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 249 FRANCE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 250 FRANCE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 251 FRANCE ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 252 FRANCE TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 253 FRANCE TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 254 FRANCE TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 255 FRANCE IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 256 FRANCE IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 257 FRANCE BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 258 FRANCE TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 259 CANADA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 260 FRANCE TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 261 FRANCE TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 262 FRANCE TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 263 ITALY TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 264 ITALY TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 265 ITALY TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 266 ITALY STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 267 ITALY STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 268 ITALY TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 269 ITALY NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 270 ITALY CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 271 ITALY PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 272 ITALY VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 273 ITALY CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 274 ITALY NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 275 ITALY CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 276 ITALY PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 277 ITALY VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 278 ITALY TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 279 ITALY REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 280 ITALY CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 281 ITALY LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 282 ITALY NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 283 ITALY CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 284 ITALY KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 285 ITALY NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 286 ITALY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 287 ITALY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 288 ITALY ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 289 ITALY TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 290 ITALY TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 291 ITALY TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 292 ITALY IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 293 ITALY IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 294 ITALY BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 295 ITALY TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 296 ITALY SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 297 ITALY TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 298 ITALY TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 299 ITALY TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 300 UK TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 301 UK TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 302 UK TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 303 UK STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 304 UK STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 305 UK TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 306 UK NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 307 UK CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 308 UK PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 309 UK VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 310 UK CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 311 UK NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 312 UK CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 313 UK PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 314 UK VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 315 UK TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 316 UK REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 317 UK CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 318 UK LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 319 UK NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 320 UK CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 321 UK KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 322 UK NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 323 UK INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 324 UK INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 325 UK ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 326 UK TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 327 UK TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 328 UKTRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 329 UK IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 330 UK IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 331 UK BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 332 UK TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 333 UK SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 334 UK TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 335 UK TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 336 UK TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 337 SPAIN TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 338 SPAIN TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 339 SPAIN TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 340 SPAIN STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 341 SPAIN STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 342 SPAIN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 343 SPAIN NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 344 SPAIN CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 345 SPAIN PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 346 SPAIN VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 347 SPAIN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 348 SPAIN NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 349 SPAIN CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 350 SPAIN PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 351 SPAIN VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 352 SPAIN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 353 SPAIN REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 354 SPAIN CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 355 SPAIN LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 356 SPAIN NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 357 SPAIN CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 358 SPAIN KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 359 SPAIN NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 360 SPAIN INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 361 SPAIN INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 362 SPAIN ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 363 SPAIN TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 364 SPAIN TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 365 SPAIN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 366 SPAIN IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 367 SPAIN IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 368 SPAIN BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 369 SPAIN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 370 SPAIN SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 371 SPAIN TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 372 SPAIN TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 373 SPAIN TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 374 SWITZERLAND TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 375 SWITZERLAND TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 376 SWITZERLAND TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 377 SWITZERLAND STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 378 SWITZERLAND STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 379 SWITZERLAND TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 380 SWITZERLAND NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 381 SWITZERLAND CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 382 SWITZERLAND PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 383 SWITZERLAND VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 384 SWITZERLAND CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 385 SWITZERLAND NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 386 SWITZERLAND CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 387 SWITZERLAND PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 388 SWITZERLAND VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 389 SWITZERLAND TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 390 SWITZERLAND REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 391 SWITZERLAND CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 392 SWITZERLAND LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 393 SWITZERLAND NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 394 SWITZERLAND CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 395 SWITZERLAND KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 396 SWITZERLAND NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 397 SWITZERLAND INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 398 SWITZERLAND INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 399 SWITZERLAND ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 400 SWITZERLAND TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 401 SWITZERLAND TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 402 SWITZERLAND TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 403 SWITZERLAND IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 404 SWITZERLAND IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 405 SWITZERLAND BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 406 SWITZERLAND TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 407 SWITZERLAND SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 408 SWITZERLAND TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 409 SWITZERLAND TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 410 SWITZERLAND TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 411 RUSSIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 412 RUSSIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 413 RUSSIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 414 RUSSIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 415 RUSSIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 416 RUSSIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 417 RUSSIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 418 RUSSIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 419 RUSSIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 420 RUSSIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 421 RUSSIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 422 RUSSIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 423 RUSSIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 424 RUSSIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 425 RUSSIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 426 RUSSIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 427 RUSSIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 428 RUSSIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 429 RUSSIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 430 RUSSIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 431 RUSSIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 432 RUSSIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 433 RUSSIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 434 RUSSIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 435 RUSSIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 436 RUSSIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 437 RUSSIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 438 RUSSIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 439 RUSSIATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 440 RUSSIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 441 RUSSIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 442 RUSSIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 443 RUSSIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 444 RUSSIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 445 RUSSIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 446 RUSSIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 447 RUSSIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 448 NETHERLANDS TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 449 NETHERLANDS TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 450 NETHERLANDS TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 451 NETHERLANDS STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 452 NETHERLANDS STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 453 NETHERLANDS TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 454 NETHERLANDS NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 455 NETHERLANDS CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 456 NETHERLANDS PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 457 NETHERLANDS VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 458 NETHERLANDS CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 459 NETHERLANDS NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 460 NETHERLANDS CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 461 NETHERLANDS PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 462 NETHERLANDS VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 463 NETHERLANDS TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 464 NETHERLANDS REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 465 NETHERLANDS CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 466 NETHERLANDS LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 467 NETHERLANDS NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 468 NETHERLANDS CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 469 NETHERLANDS KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 470 NETHERLANDS NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 471 NETHERLANDS INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 472 NETHERLANDS INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 473 NETHERLANDS ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 474 NETHERLANDS TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 475 NETHERLANDS TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 476 NETHERLANDSTRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 477 NETHERLANDS IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 478 NETHERLANDS IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 479 NETHERLANDS BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 480 NETHERLANDS TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 481 NETHERLANDS SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 482 NETHERLANDS TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 483 NETHERLANDS TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 484 NETHERLANDS TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 485 BELGIUM TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 486 BELGIUM TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 487 BELGIUM TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 488 BELGIUM STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 489 BELGIUM STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 490 BELGIUM TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 491 BELGIUM NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 492 BELGIUM CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 493 BELGIUM PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 494 BELGIUM VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 495 BELGIUM CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 496 BELGIUM NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 497 BELGIUM CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 498 BELGIUM PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 499 BELGIUM VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 500 BELGIUM TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 501 BELGIUM REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 502 BELGIUM CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 503 BELGIUM LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 504 BELGIUM NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 505 BELGIUM CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 506 BELGIUM KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 507 BELGIUM NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 508 BELGIUM INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 509 BELGIUM INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 510 BELGIUM ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 511 BELGIUM TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 512 BELGIUM TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 513 BELGIUM TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 514 BELGIUM IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 515 BELGIUM IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 516 BELGIUM BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 517 BELGIUM TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 518 BELGIUM SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 519 BELGIUM TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 520 BELGIUM TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 521 BELGIUM TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 522 TURKEY TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 523 TURKEY TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 524 TURKEY TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 525 TURKEY STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 526 TURKEY STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 527 TURKEY TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 528 TURKEY NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 529 TURKEY CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 530 TURKEY PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 531 TURKEY VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 532 TURKEY CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 533 TURKEY NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 534 TURKEY CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 535 TURKEY PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 536 TURKEY VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 537 TURKEY TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 538 TURKEY REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 539 TURKEY CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 540 TURKEY LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 541 TURKEY NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 542 TURKEY CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 543 TURKEY KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 544 TURKEY NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 545 TURKEY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 546 TURKEY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 547 TURKEY ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 548 TURKEY TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 549 TURKEY TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 550 TURKEY TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 551 TURKEY IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 552 TURKEY IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 553 TURKEY BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 554 TURKEY TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 555 TURKEY SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 556 TURKEY TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 557 TURKEY TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 558 TURKEY TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 559 REST OF EUROPE TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 560 ASIA- PACIFICTRANSFECTION MARKET, BY REGION, 2018-2028 (USD MILLION)
  • TABLE 561 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 562 ASIA-PACIFIC TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 563 ASIA-PACIFIC TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 564 ASIA-PACIFIC STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 565 ASIA-PACIFIC STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 566 ASIA-PACIFIC TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 567 ASIA-PACIFIC NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 568 ASIA-PACIFIC CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 569 ASIA-PACIFIC PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 570 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 571 ASIA-PACIFIC CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 572 ASIA-PACIFIC NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 573 ASIA-PACIFIC CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 574 ASIA-PACIFIC PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 575 ASIA-PACIFIC VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 576 ASIA-PACIFIC TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 577 ASIA-PACIFIC REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 578 ASIA-PACIFIC CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 579 ASIA-PACIFIC LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 580 ASIA-PACIFIC NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 581 ASIA-PACIFIC CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 582 ASIA-PACIFIC KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 583 ASIA-PACIFIC NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 584 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 585 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 586 ASIA-PACIFIC ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 587 ASIA-PACIFIC TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 588 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 589 ASIA-PACIFICTRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 590 ASIA-PACIFIC IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 591 ASIA-PACIFIC IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 592 ASIA-PACIFIC BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 593 ASIA-PACIFIC TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 594 ASIA-PACIFIC SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 595 ASIA-PACIFIC TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 596 ASIA-PACIFIC TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 597 ASIA-PACIFIC TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 598 CHINA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 599 CHINA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 600 CHINA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 601 CHINA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 602 CHINA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 603 CHINA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 604 CHINA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 605 CHINA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 606 CHINA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 607 CHINA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 608 CHINA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 609 CHINA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 610 CHINA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 611 CHINA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 612 CHINA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 613 CHINA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 614 CHINA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 615 CHINA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 616 CHINA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 617 CHINA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 618 CHINA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 619 CHINA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 620 CHINA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 621 CHINA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 622 CHINA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 623 CHINA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 624 CHINA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 625 CHINA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 626 CHINA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 627 CHINA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 628 CHINA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 629 CHINA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 630 CHINA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 631 CHINA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 632 CHINA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 633 CHINA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 634 CHINA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 635 JAPAN TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 636 JAPAN TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 637 JAPAN TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 638 JAPAN STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 639 JAPAN STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 640 JAPAN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 641 JAPAN NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 642 JAPAN CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 643 JAPAN PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 644 JAPAN VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 645 JAPAN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 646 JAPAN NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 647 JAPAN CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 648 JAPAN PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 649 JAPAN VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 650 JAPAN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 651 JAPAN REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 652 JAPAN CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 653 JAPAN LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 654 JAPAN NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 655 JAPAN CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 656 JAPAN KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 657 JAPAN NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 658 JAPAN INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 659 JAPAN INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 660 JAPAN ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 661 JAPAN TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 662 JAPAN TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 663 JAPAN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 664 JAPAN IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 665 JAPAN IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 666 JAPAN BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 667 JAPAN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 668 JAPAN SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 669 JAPAN TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 670 JAPAN TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 671 JAPAN TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 672 INDIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 673 INDIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 674 INDIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 675 INDIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 676 INDIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 677 INDIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 678 INDIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 679 INDIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 680 INDIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 681 INDIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 682 INDIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 683 INDIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 684 INDIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 685 INDIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 686 INDIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 687 INDIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 688 INDIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 689 INDIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 690 INDIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 691 INDIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 692 INDIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 693 INDIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 694 INDIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 695 INDIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 696 INDIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 697 INDIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 698 INDIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 699 INDIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 700 INDIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 701 INDIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 702 INDIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 703 INDIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 704 INDIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 705 INDIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 706 INDIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 707 INDIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 708 INDIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 709 AUSTRALIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 710 AUSTRALIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 711 AUSTRALIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 712 AUSTRALIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 713 AUSTRALIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 714 AUSTRALIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 715 AUSTRALIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 716 AUSTRALIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 717 AUSTRALIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 718 AUSTRALIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 719 AUSTRALIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 720 AUSTRALIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 721 AUSTRALIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 722 AUSTRALIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 723 AUSTRALIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 724 AUSTRALIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 725 AUSTRALIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 726 AUSTRALIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 727 AUSTRALIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 728 AUSTRALIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 729 AUSTRALIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 730 AUSTRALIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 731 AUSTRALIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 732 AUSTRALIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 733 AUSTRALIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 734 AUSTRALIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 735 AUSTRALIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 736 AUSTRALIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 737 AUSTRALIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 738 AUSTRALIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 739 AUSTRALIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 740 AUSTRALIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 741 AUSTRALIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 742 AUSTRALIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 743 AUSTRALIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 744 AUSTRALIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 745 AUSTRALIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 746 SOUTH KOREA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 747 SOUTH KOREA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 748 SOUTH KOREA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 749 SOUTH KOREA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 750 SOUTH KOREA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 751 SOUTH KOREA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 752 SOUTH KOREA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 753 SOUTH KOREA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 754 SOUTH KOREA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 755 SOUTH KOREA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 756 SOUTH KOREA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 757 SOUTH KOREA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 758 SOUTH KOREA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 759 SOUTH KOREA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 760 SOUTH KOREA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 761 SOUTH KOREA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 762 SOUTH KOREA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 763 SOUTH KOREA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 764 SOUTH KOREA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 765 SOUTH KOREA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 766 SOUTH KOREA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 767 SOUTH KOREA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 768 SOUTH KOREA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 769 SOUTH KOREA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 770 SOUTH KOREA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 771 SOUTH KOREA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 772 SOUTH KOREA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 773 SOUTH KOREA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 774 SOUTH KOREA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 775 SOUTH KOREA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 776 SOUTH KOREA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 777 SOUTH KOREA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 778 SOUTH KOREA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 779 SOUTH KOREA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 780 SOUTH KOREA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 781 SOUTH KOREA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 782 SOUTH KOREA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 783 SINGAPORE TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 784 SINGAPORE TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 785 SINGAPORE TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 786 SINGAPORE STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 787 SINGAPORE STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 788 SINGAPORE TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 789 SINGAPORE NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 790 SINGAPORE CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 791 SINGAPORE PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 792 SINGAPORE VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 793 SINGAPORE CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 794 SINGAPORE NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 795 SINGAPORE CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 796 SINGAPORE PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 797 SINGAPORE VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 798 SINGAPORE TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 799 SINGAPORE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 800 SINGAPORE CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 801 SINGAPORE LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 802 SINGAPORE NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 803 SINGAPORE CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 804 SINGAPORE KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 805 SINGAPORE NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 806 SINGAPORE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 807 SINGAPORE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 808 SINGAPORE ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 809 SINGAPORE TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 810 SINGAPORE TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 811 SINGAPORE TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 812 SINGAPORE IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 813 SINGAPORE IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 814 SINGAPORE BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 815 SINGAPORE TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 816 SINGAPORE SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 817 SINGAPORE TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 818 SINGAPORE TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 819 SINGAPORE TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 820 THAILAND TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 821 THAILAND TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 822 THAILAND TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 823 THAILAND STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 824 THAILAND STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 825 THAILAND TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 826 THAILAND NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 827 THAILAND CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 828 THAILAND PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 829 THAILAND VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 830 THAILAND CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 831 THAILAND NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 832 THAILAND CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 833 THAILAND PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 834 THAILAND VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 835 THAILAND TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 836 THAILAND REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 837 THAILAND CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 838 THAILAND LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 839 THAILAND NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 840 THAILAND CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 841 THAILAND KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 842 THAILAND NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 843 THAILAND INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 844 THAILAND INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 845 THAILAND ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 846 THAILAND TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 847 THAILAND TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 848 THAILAND TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 849 THAILAND IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 850 THAILAND IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 851 THAILAND BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 852 THAILAND TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 853 THAILAND SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 854 THAILAND TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 855 THAILAND TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 856 THAILAND TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 857 MALAYSIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 858 MALAYSIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 859 MALAYSIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 860 MALAYSIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 861 MALAYSIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 862 MALAYSIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 863 MALAYSIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 864 MALAYSIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 865 MALAYSIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 866 MALAYSIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 867 MALAYSIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 868 MALAYSIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 869 MALAYSIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 870 MALAYSIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 871 MALAYSIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 872 MALAYSIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 873 MALAYSIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 874 MALAYSIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 875 MALAYSIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 876 MALAYSIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 877 MALAYSIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 878 MALAYSIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 879 MALAYSIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 880 MALAYSIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 881 MALAYSIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 882 MALAYSIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 883 MALAYSIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 884 MALAYSIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 885 MALAYSIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 886 MALAYSIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 887 MALAYSIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 888 MALAYSIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 889 MALAYSIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 890 MALAYSIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 891 MALAYSIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 892 MALAYSIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 893 MALAYSIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 894 MALAYSIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 895 INDONESIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 896 INDONESIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 897 INDONESIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 898 INDONESIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 899 INDONESIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 900 INDONESIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 901 INDONESIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 902 INDONESIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 903 INDONESIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 904 INDONESIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 905 INDONESIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 906 INDONESIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 907 INDONESIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 908 INDONESIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 909 INDONESIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 910 INDONESIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 911 INDONESIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 912 INDONESIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 913 INDONESIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 914 INDONESIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 915 INDONESIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 916 INDONESIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 917 INDONESIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 918 INDONESIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 919 INDONESIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 920 INDONESIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 921 INDONESIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 922 INDONESIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 923 INDONESIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 924 INDONESIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 925 INDONESIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 926 INDONESIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 927 INDONESIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 928 INDONESIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 929 INDONESIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 930 INDONESIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 931 PHILIPPINES TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 932 PHILIPPINES TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 933 PHILIPPINES TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 934 PHILIPPINES STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 935 PHILIPPINES STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 936 PHILIPPINES TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 937 PHILIPPINES NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 938 PHILIPPINES CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 939 PHILIPPINES PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 940 PHILIPPINES VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 941 PHILIPPINES CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 942 PHILIPPINES NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 943 PHILIPPINES CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 944 PHILIPPINES PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 945 PHILIPPINES VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 946 PHILIPPINES TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 947 PHILIPPINES REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 948 PHILIPPINES CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 949 PHILIPPINES LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 950 PHILIPPINES NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 951 PHILIPPINES CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 952 PHILIPPINES KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 953 PHILIPPINES NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 954 PHILIPPINES INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 955 PHILIPPINES INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 956 PHILIPPINES ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 957 PHILIPPINES TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 958 PHILIPPINES TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 959 PHILIPPINES TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 960 PHILIPPINES IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 961 PHILIPPINES IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 962 PHILIPPINES BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 963 PHILIPPINES TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 964 PHILIPPINES SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 965 PHILIPPINES TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 966 PHILIPPINES TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 967 PHILIPPINES TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 968 REST OF ASIA- PACIFIC TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 969 SOUTH AMERICA TRANSFECTION MARKET, BY REGION, 2018-2028 (USD MILLION)
  • TABLE 970 SOUTH AMERICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 971 SOUTH AMERICA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 972 SOUTH AMERICA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 973 SOUTH AMERICA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 974 SOUTH AMERICA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 975 SOUTH AMERICA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 976 SOUTH AMERICA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 977 SOUTH AMERICA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 978 SOUTH AMERICA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 979 SOUTH AMERICA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 980 SOUTH AMERICA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 981 SOUTH AMERICA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 982 SOUTH AMERICA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 983 SOUTH AMERICA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 984 SOUTH AMERICA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 985 SOUTH AMERICA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 986 SOUTH AMERICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 987 SOUTH AMERICA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 988 SOUTH AMERICA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 989 SOUTH AMERICA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 990 SOUTH AMERICA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 991 SOUTH AMERICA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 992 SOUTH AMERICA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 993 SOUTH AMERICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 994 SOUTH AMERICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 995 SOUTH AMERICA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 996 SOUTH AMERICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 997 SOUTH AMERICA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 998 SOUTH AMERICATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 999 SOUTH AMERICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1000 SOUTH AMERICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1001 SOUTH AMERICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1002 SOUTH AMERICA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1003 SOUTH AMERICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1004 SOUTH AMERICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 1005 SOUTH AMERICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 1006 SOUTH AMERICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 1007 BRAZIL TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 1008 BRAZIL TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1009 BRAZIL TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1010 BRAZIL STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1011 BRAZIL STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1012 BRAZIL TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1013 BRAZIL NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1014 BRAZIL CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1015 BRAZIL PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1016 BRAZIL VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1017 BRAZIL CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1018 BRAZIL NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1019 BRAZIL CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1020 BRAZIL PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1021 BRAZIL VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1022 BRAZIL TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1023 BRAZIL REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1024 BRAZIL CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1025 BRAZIL LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1026 BRAZIL NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1027 BRAZIL CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1028 BRAZIL KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1029 BRAZIL NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1030 BRAZIL INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1031 BRAZIL INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 1032 BRAZIL ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1033 BRAZIL TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 1034 BRAZIL TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 1035 BRAZIL TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1036 BRAZIL IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1037 BRAZIL IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1038 BRAZIL BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1039 BRAZIL TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1040 BRAZIL SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1041 BRAZIL TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 1042 BRAZIL TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 1043 BRAZIL TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 1044 ARGENTINA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 1045 ARGENTINA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1046 ARGENTINA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1047 ARGENTINA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1048 ARGENTINA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1049 ARGENTINA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1050 ARGENTINA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1051 ARGENTINA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1052 ARGENTINA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1053 ARGENTINA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1054 ARGENTINA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1055 ARGENTINA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1056 ARGENTINA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1057 ARGENTINA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1058 ARGENTINA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1059 ARGENTINA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1060 ARGENTINA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1061 ARGENTINA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1062 ARGENTINA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1063 ARGENTINA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1064 ARGENTINA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1065 ARGENTINA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1066 ARGENTINA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1067 ARGENTINA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1068 ARGENTINA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 1069 ARGENTINA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1070 ARGENTINA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 1071 ARGENTINA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 1072 ARGENTINA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1073 ARGENTINA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1074 ARGENTINA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1075 ARGENTINA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1076 ARGENTINA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1077 ARGENTINA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1078 ARGENTINA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 1079 ARGENTINA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 1080 ARGENTINA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 1081 REST OF SOUTH AMERICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 1082 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY REGION, 2018-2028 (USD MILLION)
  • TABLE 1083 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 1084 MIDDLE EAST & AFRICA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1085 MIDDLE EAST & AFRICA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1086 MIDDLE EAST & AFRICA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1087 MIDDLE EAST & AFRICA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1088 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1089 MIDDLE EAST & AFRICA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1090 MIDDLE EAST & AFRICA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1091 MIDDLE EAST & AFRICA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1092 MIDDLE EAST & AFRICA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1093 MIDDLE EAST & AFRICA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1094 MIDDLE EAST & AFRICA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1095 MIDDLE EAST & AFRICA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1096 MIDDLE EAST & AFRICA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1097 MIDDLE EAST & AFRICA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1098 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1099 MIDDLE EAST & AFRICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1100 MIDDLE EAST & AFRICA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1101 MIDDLE EAST & AFRICA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1102 MIDDLE EAST & AFRICA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1103 MIDDLE EAST & AFRICA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1104 MIDDLE EAST & AFRICA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1105 MIDDLE EAST & AFRICA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1106 MIDDLE EAST & AFRICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1107 MIDDLE EAST & AFRICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 1108 MIDDLE EAST & AFRICA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1109 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 1110 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 1111 MIDDLE EAST & AFRICATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1112 MIDDLE EAST & AFRICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1113 MIDDLE EAST & AFRICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1114 MIDDLE EAST & AFRICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1115 MIDDLE EAST & AFRICA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1116 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1117 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 1118 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 1119 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 1120 SOUTH AFRICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 1121 SOUTH AFRICA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1122 SOUTH AFRICA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1123 SOUTH AFRICA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1124 SOUTH AFRICA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1125 SOUTH AFRICA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1126 SOUTH AFRICA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1127 SOUTH AFRICA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1128 SOUTH AFRICA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1129 SOUTH AFRICA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1130 SOUTH AFRICA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1131 SOUTH AFRICA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1132 SOUTH AFRICA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1133 SOUTH AFRICA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1134 SOUTH AFRICA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1135 SOUTH AFRICA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1136 SOUTH AFRICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1137 SOUTH AFRICA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1138 SOUTH AFRICA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1139 SOUTH AFRICA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1140 SOUTH AFRICA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1141 SOUTH AFRICA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1142 SOUTH AFRICA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1143 SOUTH AFRICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1144 SOUTH AFRICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 1145 SOUTH AFRICA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1146 SOUTH AFRICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 1147 SOUTH AFRICA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 1148 SOUTH AFRICA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1149 SOUTH AFRICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1150 SOUTH AFRICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1151 SOUTH AFRICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1152 SOUTH AFRICA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1153 SOUTH AFRICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1154 SOUTH AFRICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 1155 SOUTH AFRICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 1156 SOUTH AFRICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 1157 SAUDI ARABIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 1158 SAUDI ARABIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1159 SAUDI ARABIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1160 SAUDI ARABIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1161 SAUDI ARABIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1162 SAUDI ARABIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1163 SAUDI ARABIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1164 SAUDI ARABIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1165 SAUDI ARABIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1166 SAUDI ARABIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1167 SAUDI ARABIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1168 SAUDI ARABIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1169 SAUDI ARABIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1170 SAUDI ARABIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1171 SAUDI ARABIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1172 SAUDI ARABIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1173 SAUDI ARABIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1174 SAUDI ARABIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1175 SAUDI ARABIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1176 SAUDI ARABIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1177 SAUDI ARABIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1178 SAUDI ARABIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1179 SAUDI ARABIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1180 SAUDI ARABIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1181 SAUDI ARABIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 1182 SAUDI ARABIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1183 SAUDI ARABIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 1184 SAUDI ARABIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 1185 SAUDI ARABIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1186 SAUDI ARABIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1187 SAUDI ARABIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1188 SAUDI ARABIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1189 SAUDI ARABIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1190 SAUDI ARABIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1191 SAUDI ARABIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 1192 SAUDI ARABIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 1193 SAUDI ARABIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 1194 UAE TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 1195 UAE TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1196 UAE TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1197 UAE STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1198 UAE STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1199 UAE TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1200 UAE NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1201 UAE CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1202 UAE PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1203 UAE VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1204 UAE CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1205 UAE NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1206 UAE CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1207 UAE PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1208 UAE VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1209 UAE TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1210 UAE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1211 UAE CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1212 UAE LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1213 UAE NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1214 UAE CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1215 UAE KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1216 UAE NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1217 UAE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1218 UAE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 1219 UAE ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1220 UAE TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 1221 UAE TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 1222 UAE TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1223 UAE IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1224 UAE IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1225 UAE BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1226 UAE TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1227 UAE SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1228 UAE TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 1229 UAE TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 1230 UAE TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 1231 ISRAEL TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 1232 ISRAEL TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1233 ISRAEL TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1234 ISRAEL STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1235 ISRAEL STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1236 ISRAEL TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1237 ISRAEL NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1238 ISRAEL CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1239 ISRAEL PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1240 ISRAEL VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1241 ISRAEL CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1242 ISRAEL NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1243 ISRAEL CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1244 ISRAEL PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1245 ISRAEL VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1246 ISRAEL TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1247 ISRAEL REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1248 ISRAEL CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1249 ISRAEL LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1250 ISRAEL NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1251 ISRAEL CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1252 ISRAEL KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1253 ISRAEL NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1254 ISRAEL INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1255 ISRAEL INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 1256 ISRAEL ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1257 ISRAEL TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 1258 ISRAEL TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 1259 ISRAEL TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1260 ISRAEL IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1261 ISRAEL IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1262 ISRAEL BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1263 ISRAEL TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1264 ISRAEL SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1265 ISRAEL TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 1266 ISRAEL TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 1267 ISRAEL TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 1268 EGYPT TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 1269 EGYPT TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1270 EGYPT TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1271 EGYPT STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1272 EGYPT STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 1273 EGYPT TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1274 EGYPT NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1275 EGYPT CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1276 EGYPT PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1277 EGYPT VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1278 EGYPT CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1279 EGYPT NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1280 EGYPT CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1281 EGYPT PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1282 EGYPT VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 1283 EGYPT TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1284 EGYPT REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1285 EGYPT CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1286 EGYPT LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1287 EGYPT NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1288 EGYPT CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1289 EGYPT KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1290 EGYPT NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1291 EGYPT INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1292 EGYPT INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 1293 EGYPT ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 1294 EGYPT TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 1295 EGYPT TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 1296 EGYPT TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1297 EGYPT IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1298 EGYPT IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1299 EGYPT BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1300 EGYPT TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1301 EGYPT SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 1302 EGYPT TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 1303 EGYPT TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 1304 EGYPT TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 1305 REST OF MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL TRANSFECTION MARKET: SEGMENTATION 98
  • FIGURE 2 GLOBAL TRANSFECTION MARKET : DATA TRIANGULATION 101
  • FIGURE 3 GLOBAL TRANSFECTION MARKET: DROC ANALYSIS 102
  • FIGURE 4 GLOBAL TRANSFECTION MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 103
  • FIGURE 5 GLOBAL TRANSFECTION MARKET: COMPANY RESEARCH ANALYSIS 103
  • FIGURE 6 GLOBAL TRANSFECTION MARKET: MULTIVARIATE MODELLING 104
  • FIGURE 7 GLOBAL TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS 106
  • FIGURE 8 GLOBAL TRANSFECTION MARKET: DBMR MARKET POSITION GRID 107
  • FIGURE 9 GLOBAL TRANSFECTION MARKET: MARKET APPLICATION COVERAGE GRID 108
  • FIGURE 10 GLOBAL TRANSFECTION MARKET: VENDOR SHARE ANALYSIS 109
  • FIGURE 11 GLOBAL TRANSFECTION MARKET: SEGMENTATION 113
  • FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE AND ASIA-PACIFIC IS GROWING AT THE FASTEST PACE IN THE GLOBAL TRANSFECTION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 115
  • FIGURE 13 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE GLOBAL TRANSFECTION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 116
  • FIGURE 14 TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL TRANSFECTION MARKET IN 2021 & 2028 117
  • FIGURE 15 NORTH AMERICA IS THE FASTEST GROWING MARKET IN GLOBAL TRANSFECTION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 118
  • FIGURE 16 APPROVAL PROCESS FOR GENE THERAPY IN CHINA 124
  • FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL TRANSFECTION MARKET 127
  • FIGURE 18 GLOBAL TRANSFECTION MARKET: BY TYPE, 2020 142
  • FIGURE 19 GLOBAL TRANSFECTION MARKET: BY TYPE, 2020-2028 (USD MILLION) 143
  • FIGURE 20 GLOBAL TRANSFECTION MARKET: BY TYPE, CAGR (2021-2028) 143
  • FIGURE 21 GLOBAL TRANSFECTION MARKET: BY TYPE, LIFELINE CURVE 144
  • FIGURE 22 GLOBAL TRANSFECTION MARKET: BY METHODS, 2020 150
  • FIGURE 23 GLOBAL TRANSFECTION MARKET: BY METHODS, 2020-2028 (USD MILLION) 151
  • FIGURE 24 GLOBAL TRANSFECTION MARKET: BY METHODS, CAGR (2021-2028) 151
  • FIGURE 25 GLOBAL TRANSFECTION MARKET: BY METHODS, LIFELINE CURVE 152
  • FIGURE 26 GLOBAL TRANSFECTION MARKET: BY METHODS, 2020 159
  • FIGURE 27 GLOBAL TRANSFECTION MARKET: BY METHODS, 2020-2028 (USD MILLION) 160
  • FIGURE 28 GLOBAL TRANSFECTION MARKET: BY METHODS, CAGR (2021-2028) 160
  • FIGURE 29 GLOBAL TRANSFECTION MARKET: BY METHODS, LIFELINE CURVE 161
  • FIGURE 30 GLOBAL TRANSFECTION MARKET: BY PRODUCT, 2020 168
  • FIGURE 31 GLOBAL TRANSFECTION MARKET: BY PRODUCT, 2020-2028 (USD MILLION) 169
  • FIGURE 32 GLOBAL TRANSFECTION MARKET: BY PRODUCT, CAGR (2021-2028) 169
  • FIGURE 33 GLOBAL TRANSFECTION MARKET: BY PRODUCT, LIFELINE CURVE 170
  • FIGURE 34 GLOBAL TRANSFECTION MARKET: BY ORGANISM, 2020 183
  • FIGURE 35 GLOBAL TRANSFECTION MARKET: BY ORGANISM, 2020-2028 (USD MILLION) 184
  • FIGURE 36 GLOBAL TRANSFECTION MARKET: BY ORGANISM, CAGR (2021-2028) 184
  • FIGURE 37 GLOBAL TRANSFECTION MARKET: BY ORGANISM, LIFELINE CURVE 185
  • FIGURE 38 GLOBAL TRANSFECTION MARKET: BY TYPES OF MOLECULE, 2020 191
  • FIGURE 39 GLOBAL TRANSFECTION MARKET: BY TYPES OF MOLECULE, 2020-2028 (USD MILLION) 192
  • FIGURE 40 GLOBAL TRANSFECTION MARKET: BY TYPES OF MOLECULE, CAGR (2021-2028) 192
  • FIGURE 41 GLOBAL TRANSFECTION MARKET: BY TYPES OF MOLECULE LIFELINE CURVE 193
  • FIGURE 42 GLOBAL TRANSFECTION MARKET: BY APPLICATION, 2020 200
  • FIGURE 43 GLOBAL TRANSFECTION MARKET: BY APPLICATION, 2020-2028 (USD MILLION) 202
  • FIGURE 44 GLOBAL TRANSFECTION MARKET: BY APPLICATION, CAGR (2021-2028) 202
  • FIGURE 45 GLOBAL TRANSFECTION MARKET: BY APPLICATION, LIFELINE CURVE 203
  • FIGURE 46 GLOBAL TRANSFECTION MARKET: BY STAGES, 2020 214
  • FIGURE 47 GLOBAL TRANSFECTION MARKET: BY STAGES, 2020-2028 (USD MILLION) 215
  • FIGURE 48 GLOBAL TRANSFECTION MARKET: BY STAGES, CAGR (2021-2028) 215
  • FIGURE 49 GLOBAL TRANSFECTION MARKET: BY STAGES, LIFELINE CURVE 216
  • FIGURE 50 GLOBAL TRANSFECTION MARKET: BY END USER, 2020 222
  • FIGURE 51 GLOBAL TRANSFECTION MARKET: BY END USER, 2020-2028 (USD MILLION) 223
  • FIGURE 52 GLOBAL TRANSFECTION MARKET: BY END USER, CAGR (2021-2028) 223
  • FIGURE 53 GLOBAL TRANSFECTION MARKET: BY END USER, LIFELINE CURVE 224
  • FIGURE 54 GLOBAL TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, 2020 232
  • FIGURE 55 GLOBAL TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION) 233
  • FIGURE 56 GLOBAL TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028) 233
  • FIGURE 57 GLOBAL TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 234
  • FIGURE 1 GLOBAL TRANSFECTION MARKET: SNAPSHOT (2020) 240
  • FIGURE 2 GLOBAL TRANSFECTION MARKET: BY REGION (2020) 242
  • FIGURE 3 GLOBAL TRANSFECTION MARKET: BY REGION (2021 & 2028) 242
  • FIGURE 4 GLOBAL TRANSFECTION MARKET: BY REGION (2020 & 2028) 243
  • FIGURE 5 GLOBAL TRANSFECTION MARKET: BY TYPE (2021-2028) 243
  • FIGURE 6 NORTH AMERICA TRANSFECTION MARKET: SNAPSHOT (2020) 245
  • FIGURE 7 NORTH AMERICA TRANSFECTION MARKET: BY COUNTRY (2020) 247
  • FIGURE 8 NORTH AMERICA TRANSFECTION MARKET: BY COUNTRY (2021 & 2028) 247
  • FIGURE 9 NORTH AMERICA TRANSFECTION MARKET: BY COUNTRY (2020 & 2028) 248
  • FIGURE 10 NORTH AMERICA TRANSFECTION MARKET: BY TYPE (2021-2028) 248
  • FIGURE 11 EUROPE TRANSFECTION MARKET: SNAPSHOT (2020) 306
  • FIGURE 12 EUROPE TRANSFECTION MARKET: BY COUNTRY (2020) 308
  • FIGURE 13 EUROPE TRANSFECTION MARKET: BY COUNTRY (2021 & 2028) 308
  • FIGURE 14 EUROPE TRANSFECTION MARKET: BY COUNTRY (2020 & 2028) 309
  • FIGURE 15 EUROPE TRANSFECTION MARKET: BY TYPE (2021-2028) 309
  • FIGURE 16 ASIA-PACIFIC TRANSFECTION MARKET: SNAPSHOT (2020) 469
  • FIGURE 17 ASIA-PACIFIC TRANSFECTION MARKET: BY COUNTRY (2020) 471
  • FIGURE 18 ASIA-PACIFIC TRANSFECTION MARKET: BY COUNTRY (2021 & 2028) 471
  • FIGURE 19 ASIA-PACIFIC TRANSFECTION MARKET: BY COUNTRY (2020 & 2028) 472
  • FIGURE 20 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE (2021-2028) 472
  • FIGURE 21 SOUTH AMERICA TRANSFECTION MARKET: SNAPSHOT (2020) 617
  • FIGURE 22 SOUTH AMERICA TRANSFECTION MARKET: BY COUNTRY (2020) 619
  • FIGURE 23 SOUTH AMERICA TRANSFECTION MARKET: BY COUNTRY (2021 & 2028) 619
  • FIGURE 24 SOUTH AMERICA TRANSFECTION MARKET: BY COUNTRY (2020 & 2028) 620
  • FIGURE 25 SOUTH AMERICA TRANSFECTION MARKET: BY TYPE (2021-2028) 620
  • FIGURE 26 MIDDLE EAST & AFRICA TRANSFECTION MARKET: SNAPSHOT (2020) 661
  • FIGURE 27 MIDDLE EAST & AFRICA TRANSFECTION MARKET: BY COUNTRY (2020) 663
  • FIGURE 28 MIDDLE EAST & AFRICA TRANSFECTION MARKET: BY COUNTRY (2021 & 2028) 663
  • FIGURE 29 MIDDLE EAST & AFRICA TRANSFECTION MARKET: BY COUNTRY (2020 & 2028) 664
  • FIGURE 30 MIDDLE EAST & AFRICA TRANSFECTION MARKET: BY TYPE (2021-2028) 664
  • FIGURE 31 GLOBAL TRANSFECTION MARKET: COMPANY SHARE 2020 (%) 745
  • FIGURE 32 NORTH AMERICA TRANSFECTION MARKET: COMPANY SHARE 2020 (%) 746
  • FIGURE 33 EUROPE TRANSFECTION MARKET: COMPANY SHARE 2020 (%) 747
  • FIGURE 34 ASIA-PACIFIC TRANSFECTION MARKET: COMPANY SHARE 2020 (%)